Xyme Limited

Class 001: De novo enzymes for industrial, agricultural, domestic and commercial purposes designed by AI; enzymes for industrial, agricultural, domestic and commercial purposes with AI-designed catalytic sites; enzymes for industrial, agricultural, domestic and commercial purposes with AI-designed tertiary structure; purified enzymes for industrial, agricultural, domestic and commercial purposes for catalysis of chemical reactions; enzymes for industrial, agricultural, domestic and commercial purposes for the production of chemical products; enzymes for industrial, agricultural, domestic and commercial purposes for novel synthetic pathways; purified enzymes for scientific and research purposes for treatment of diseases; purified enzymes for industrial, agricultural, domestic and commercial purposes for the production of biofuels; enzymes for industrial, agricultural, domestic and commercial purposes for carbon dioxide capture and conversion; enzymes for biocatalysis, purified enzymatic non-living organism in the form of a catalyst solution for chemical and biochemical processes for industrial, agricultural, domestic and commercial purposes; purified enzymes for industrial, agricultural, domestic and commercial purposes for degradation of materials; aqueous and non-aqueous enzyme solutions for industrial use in catalytic reactors; aqueous and non-aqueous enzyme solutions for industrial, agricultural, domestic and commercial purposes for technical use; aqueous and non-aqueous enzyme solutions for industrial, agricultural, domestic and commercial purposes for chemical catalysis and biocatalysis; enzymes for industrial, agricultural, domestic and commercial purposes immobilised on support materials, including, nanoparticles, chitosan and collagen fibers; Class 004: Biofuels; biomass fuel; fuels from biological sources; alcohol fuel; carburants motor fuel; diesel oil and gas oil; ethanol fuel; fuel gas; fuel oil and combustible oil; fuel with an alcohol base; kerosene; naphtha; Class 005: aqueous and non-aqueous enzyme solutions for therapeutic medical and medical applications; Class 009: Downloadable software for the design of enzymes; Downloadable software for the design of de novo enzymes; Downloadable software for the design of catalytic sites of enzymes; Downloadable software for the design of tertiary structure of enzymes; Downloadable software to optimise properties of enzymes including, solubility and stability; Downloadable software to predict enzyme structure; Downloadable software to design and predict stabilising enzyme conformations during catalysis; downloadable computer software using artificial intelligence and machine learning models for the design of de novo enzymes; artificial intelligence and machine learning models for the design of catalytic sites of enzymes; downloadable computer software using artificial intelligence and machine learning models for the design of tertiary structure of enzymes; downloadable computer software using artificial intelligence and machine learning models for the design of properties of enzymes including solubility and stability; downloadable computer software using artificial intelligence and machine learning models for the prediction of enzyme structure; downloadable computer software using artificial intelligence and machine learning models for the design and prediction of stabilising enzyme conformations during catalysis; Downloadable software for the design of enzymes for customers for applications in chemistry, therapeutics and technical industries; downloadable reports and downloadable electronic publications in the nature of articles, newsletters, information sheets and brochures in the field of enzyme design; Class 042: Design of enzymes; design of de novo enzymes; design of catalytic sites of enzymes; design of tertiary structure of enzymes; technical design and consultancy services relating to the optimisation of properties of enzymes including solubility and stability; technical design and consultancy services relation to the prediction of enzyme structure; technical design and consultancy services relating to the design and prediction of enzyme conformations during catalysis; software as a service featuring software for the design of enzymes; software as a service featuring software for the design of de novo enzymes; software as a service featuring software for the design of catalytic sites of enzymes; software as a service featuring software for the design of tertiary structure of enzymes; software as a service featuring software to optimise properties of enzymes including solubility and stability; software as a service featuring software to predict enzyme structure; software as a services featuring software to design and predict stabilising enzyme conformations during catalysis; updating and maintenance of computer software for enzyme design; information, advisory and consultancy services relating to all of the aforesaid